THE IMPACT OF DISCOUNTING ON THE COST EFFECTIVENESS OF TISAGENLECLEUCEL FOR RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKAEMIA

被引：0
|
作者：
Carey, N. [1 ]
Mccullagh, L. [1 ]
Barry, M. [1 ]
机构：
[1] Natl Ctr Pharmacoecon, Dublin, Ireland
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 01期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
POSB125
引用
收藏
页码：S85 / S86
页数：2
相关论文
共 50 条
  • [21] Imatinib - In relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia
    Cross, Sarah A.
    Lyseng-Williamson, Katherine A.
    DRUGS, 2007, 67 (17) : 2645 - 2654
  • [22] Tisagenlecleucel for treatment of children and young adults with relapsed/refractory B-cell acute lymphoblastic leukemia
    Si Lim, Stephanie J.
    Grupp, Stephen A.
    DiNofia, Amanda M.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (09)
  • [23] Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma
    Mueller, Karen Thudium
    Grupp, Stephan A.
    Maude, Shannon L.
    Levine, John E.
    Pulsipher, Michael A.
    Boyer, Michael W.
    August, Keith J.
    Myers, G. Doug
    Tam, Constantine S.
    Jaeger, Ulrich
    Foley, Stephen Ronan
    Borchmann, Peter
    Schuster, Stephen J.
    Waller, Edmund K.
    Awasthi, Rakesh
    Potthoff, Bernd
    Warren, Andy
    Waldron, Edward R.
    McBlane, Fraser
    Chassot-Agostinho, Andrea
    Laetsch, Theodore W.
    BLOOD ADVANCES, 2021, 5 (23) : 4980 - 4991
  • [24] Safety and effectiveness of clofarabine in Japanese patients with relapsed/refractory acute lymphoblastic leukaemia: a post-marketing surveillance study
    Kazama, Hirotaka
    Nishina, Satoshi
    Seto, Takeshi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (07) : 778 - 786
  • [25] Inotuzumab Ozogamicin: A Review in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukaemia
    Zaina T. Al-Salama
    Targeted Oncology, 2018, 13 : 525 - 532
  • [26] Inotuzumab Ozogamicin: A Review in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukaemia
    Al-Salama, Zaina T.
    TARGETED ONCOLOGY, 2018, 13 (04) : 525 - 532
  • [27] A Study of Aberrant DNA Methylation in Refractory and Relapsed Childhood Acute Lymphoblastic Leukaemia.
    Kapatai, Georgia
    Nyangoma, Stephen O.
    Kearns, Pamela
    BLOOD, 2009, 114 (22) : 1343 - 1343
  • [28] French "real life" experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia
    Trioche, Pascale
    Nelken, Brigitte
    Michel, Gerard
    Pellier, Isabelle
    Petit, Arnaud
    Bertrand, Yves
    Rohrlich, Pierre
    Schmitt, Claudine
    Sirvent, Nicolas
    Boutard, Patrick
    Margueritte, Genevieve
    Pautard, Brigitte
    Ducassou, Stephane
    Plantaz, Dominique
    Robert, Alain
    Thomas, Caroline
    Desseaux, Kristell
    Chevret, Sylvie
    Baruchel, Andre
    EXPERIMENTAL HEMATOLGY & ONCOLOGY, 2012, 1
  • [29] French “real life” experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia
    Pascale Trioche
    Brigitte Nelken
    Gérard Michel
    Isabelle Pellier
    Arnaud Petit
    Yves Bertrand
    Pierre Rohrlich
    Claudine Schmitt
    Nicolas Sirvent
    Patrick Boutard
    Geneviève Margueritte
    Brigitte Pautard
    Stéphane Ducassou
    Dominique Plantaz
    Alain Robert
    Caroline Thomas
    Kristell Desseaux
    Sylvie Chevret
    André Baruchel
    Experimental Hematology & Oncology, 1 (1)
  • [30] Single Centre Cohort Study of Monitoring B Cell Populations in the Bone Marrow and Peripheral Blood Post Tisagenlecleucel Therapy of Relapsed/Refractory Acute Lymphoblastic Leukaemia
    Fernandes, Sneha
    Rauthan, Archana
    Epuelas, Macarena Oporto
    Berry, Katherine
    Burridge, Saskia
    Twigdon-Williams, Charlotte
    Connor, Christopher
    Davis, Mark
    Gilmour, Kimberly
    Thomas, Rebecca
    Ancliff, Phil
    Bartram, Jack
    Chiesa, Robert
    Lucchini, Giovanna
    Pavasovic, Vesna
    Rao, Anupama
    Rao, Kanchan
    Samarasinghe, Sujith
    Silva, Juliana
    Vora, Ajay
    Amrolia, Persis
    Ghorashian, Sara
    BLOOD, 2023, 142
12345